Premarket Stock Movers — July 1, 2026: Why DXF, LHAI, LGCL, CELZ & CANF Are Surging

DXF — Eason Technology Ltd (+147.3%)

Eason Technology is exploding +147.3% to $0.90 in Wednesday's premarket, printing 58.9 million shares against a 20-day average of just 1.54 million — roughly 38× its normal daily volume before the opening bell. That kind of volume ratio in a sub-$1 name demands immediate attention and equal caution.

Why it's moving: No company-specific press release or SEC filing clearly explains this morning's spike. The most recent headline on file — from Yahoo Finance on June 29 — is a broad roundup of American Depositary Receipts (ADRs) trading higher, not a DXF-specific catalyst. A routine 6-K (a required disclosure form for foreign private issuers) was filed June 8 but carried a neutral event tag. With no identifiable fundamental catalyst, this move looks momentum- and technically-driven, likely amplified by its extremely thin trading history.

The prior-day chart through June 30 paints a challenging technical backdrop: the MA (moving average) stack is bearish, RSI sits at just 38 (below the neutral 50 line), ADX at 18 signals a weak trend, and StockSetups assigns a conviction score of 0/100 with a D grade and a trend-template score of 0. The stock is sitting 94.4% below its 52-week high — meaning it has given up almost everything from peak levels. Short interest is negligible (89,859 shares, squeeze score 8/100), so a short squeeze is very unlikely to be the driver here.

Moves like this in micro-cap ADRs with no visible catalyst and extreme volume surges are among the most dangerous to chase. The regular session has not yet opened, and premarket prices on thin-float names can shift dramatically once the broader market begins trading.

LHAI — Linkhome Holdings Inc. (+134.8%)

Linkhome Holdings is surging +134.8% to $1.72 on massive premarket volume of 94.3 million shares — versus a 20-day average of just 95,876. That is roughly 985× its typical daily volume, an extraordinary reading that reflects a flood of order flow into an extremely thinly traded name.

Why it's moving: This one has a clear catalyst. Per GlobeNewswire and Yahoo Finance this morning (July 1), Linkhome has completed the acquisition of Mortgage One Group and simultaneously launched a GPU financing business. The dual announcement — a bolt-on acquisition in mortgage services combined with an entry into GPU (graphics processing unit) financing, a space tied to AI infrastructure demand — is the kind of headline that can send a micro-cap stock parabolic in premarket trading.

The prior-day technical setup is weak on fundamentals: bearish MA stack, RSI 35, conviction 0/100, D grade, trend-template 0, and the stock is 95.6% below its 52-week high. With a free float of 50.1% and only 50,747 shares short (squeeze score 5/100, 0.7 days to cover), a classic short squeeze is not the story here — it's pure news-driven buying into a very small float. The ADX at 34 does indicate a strengthening directional move, which may reflect the surge already under way heading into today.

News-driven gaps (a gap is when a stock opens substantially above or below its prior close with no trades in between) on micro-cap financials can be swift and brutal reversals once early buyers take profits. The company's market cap was just $11.0 million at the prior close — even with today's surge, it remains a nano-cap with all the associated liquidity risks.

LGCL — Lucas GC Ltd (+101.1%)

Lucas GC is doubling this morning, +101.1% to $1.70, on 1.18 million premarket shares — below its 20-day average of 4.08 million, which is notable. The move is happening on lighter-than-normal volume for this name, meaning conviction behind the gap is not yet confirmed by heavy participation.

Why it's moving: No press release or specific headline is on file for LGCL this morning. Given the absence of a news catalyst, this move appears technically and momentum-driven. The stock's low free float of 38.6% (meaning only 38.6% of total shares are freely tradable in the market) means even modest buying interest can produce outsized price swings — a key dynamic to understand with names like this.

The prior-day setup through June 30 is the most technically interesting of today's premarket movers: LGCL carries a bullish belt hold candlestick — a single-bar reversal pattern where the stock opens at or near its low and rallies strongly to close near its high — paired with an RS rating of 98 (meaning it has outperformed 98% of all stocks over the prior year). RSI is 56 (neutral-to-constructive), the MA stack is mixed, and StockSetups assigns a conviction score of 47/100 with a C grade and trend-template score of 4 — the strongest technical profile among today's premarket movers. However, two 424B5 filings (follow-on share offerings, flagged as bearish) in June signal potential dilution risk that traders should weigh carefully. The squeeze score is 29/100 with 53% short-volume, suggesting some short-side activity but not an extreme squeeze setup.

CELZ — Creative Medical Technology Holdings (+71.8%)

Creative Medical Technology is up +71.8% to $1.40 in premarket, with 1.03 million shares traded versus a 20-day average of 5.93 million — again, below-average volume behind a large percentage move, which is a flag worth noting. Most strikingly, the gap into today's session is +221.5% on the technical data — reflecting that yesterday's after-hours/premarket price action has produced an enormous implied gap versus the prior regular-session close.

Why it's moving: Per Investing.com (June 30), Creative Medical secured $4.5 million through a warrant exercise deal. A warrant exercise means existing warrant holders (investors with the right to buy shares at a preset price) chose to exercise those rights, injecting $4.5 million into the company. For a company with a market cap of just $5.2 million, a $4.5M capital raise is substantial relative to its size and relieves near-term financing pressure — explaining the enthusiastic premarket response. The move was already flagged in Benzinga's after-hours healthcare movers recap on June 30, meaning some of this gap was building overnight.

The prior-day technical picture is bearish overall: MA stack bearish, RSI 38, conviction 24/100, D grade, trend-template 1. But the squeeze score of 49/100 is the highest among today's five movers, and with 2.9 days to cover (meaning short sellers would need 2.9 days of average volume to fully close their positions) and 56% short-volume, there is a meaningful short-squeeze component potentially layered on top of the news catalyst. A short squeeze occurs when rising prices force short sellers — those who bet against a stock — to buy shares to cover their positions, accelerating the upward move. The nearly-full float (99.1% free float) limits the structural squeeze fuel, however.

CANF — Can-Fite BioPharma Ltd. (+57.3%)

Can-Fite BioPharma is jumping +57.3% to $4.50 this morning on 22.9 million shares — nearly 17× its 20-day average of 1.33 million. This is the most liquid premarket move of the five names today and carries the clearest fundamental catalyst.

Why it's moving: Multiple sources this morning — including Yahoo Finance, TipRanks, GuruFocus, and Stock Titan — report that Can-Fite's Phase 2a pancreatic cancer study with Namodenoson has achieved its primary safety endpoint and demonstrated durable survival outcomes in advanced disease. TipRanks describes the drug as hitting a safety goal and showing a durable survival signal; Stock Titan notes a survival signal in the Phase 2a readout. For a small-cap biotech, achieving a primary endpoint in an oncology trial — especially in a notoriously difficult-to-treat cancer like advanced pancreatic cancer — is a major value-inflection event that can justify large single-day moves.

The prior-day chart through June 30 shows an inverted hammer candlestick — a single candle with a long upper wick that, when appearing after a downtrend, can signal a potential reversal (though confirmation is needed). RSI is 41, ADX 19, the MA stack is mixed, and the stock sits 52.8% below its 52-week high. StockSetups gives a conviction score of 27/100, a D grade, but a trend-template score of 4 and an RS rating of 98 — the same elite relative-strength reading as LGCL, reflecting strong recent price performance among the full US stock universe. Short interest is relatively low (47,052 shares, squeeze score 12/100, 14% short-volume), so this is a news-driven move, not a squeeze. The 100% free float means all shares are in circulation, providing more liquidity than most of today's other movers.

Clinical trial results can be volatile in both directions — positive Phase 2a data does not guarantee Phase 3 success or regulatory approval, and biotech stocks frequently give back a large portion of clinical-catalyst gains in the days that follow.

The Bottom Line

This morning's premarket leaderboard is a vivid reminder of how quickly small and micro-cap stocks can move on thin pre-open volume. LHAI has the clearest catalyst — a completed acquisition plus a new GPU financing business. CANF has the most substantive fundamental news — a positive Phase 2a oncology readout. CELZ is reacting to a capital raise that is large relative to its tiny market cap. LGCL is doubling with no visible catalyst on below-average volume, driven by its tight float. And DXF is up 147% with no identifiable company-specific reason at all.

A few things to keep front of mind before the 9:30 AM ET open:

• Premarket prices are not opening prices. Thin premarket liquidity means spreads are wide and prices can move sharply before the regular session begins — in either direction.
• Chasing extended premarket gainers is high-risk. Stocks up 50–150% before the open frequently give back a significant portion of those gains once normal volume flows in. Failed breakouts and bull traps are common after parabolic opens.
• Every name here is a micro-cap or nano-cap. Low market caps mean low liquidity, wider spreads, and faster reversals. Use position sizing accordingly — never risk more than you can afford to lose on a single idea.
• Technical patterns and squeeze setups can and do fail. Even LGCL's constructive prior-day setup — the strongest of the five — does not guarantee follow-through once the broader market opens.
• This is educational content, not financial advice. Do your own research and consult a financial professional before making any trading decision. Consider having a written trading plan before you act on any of these names.

StockSetups scans the full ~12,300-stock US universe every premarket morning, detecting chart patterns, computing conviction and squeeze scores, and surfacing the names with the most technical and momentum relevance — so you're never starting the day cold. Check back after the close for a full recap of how today's movers fared in the regular session.

Previously on StockSetups: Premarket Stock Movers — June 30, 2026: Why JEM, SVRE, CELZ, AVXX & BTCT Were Surging | Top Stock Movers — June 30, 2026: Why JEM, LGCL, JBDI, YOOV & BIYA Surged